WAVE Life Sciences Ltd (NAS:WVE)
$ 13.41 0.29 (2.21%) Market Cap: 2.05 Bil Enterprise Value: 1.76 Bil PE Ratio: 0 PB Ratio: 14.06 GF Score: 45/100

WAVE Life Sciences Ltd Corporate Call Transcript

Dec 30, 2019 / 01:00PM GMT
Release Date Price: $7.99 (-49.46%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Wave Life Sciences' PRECISION-HD2 Top Line Results Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Kate Rausch, Head of Investor Relations at Wave Life Sciences. Please go ahead.

Kate Rausch
Wave Life Sciences Ltd. - Head of IR

Thank you, operator. Good morning, and thank you for joining us. With me here today is Dr. Paul Bolno, President and CEO of Wave Life Sciences; and Dr. Mike Panzara, Wave's Chief Medical Officer.

This morning, we issued a news release announcing top line data from our PRECISION-HD2 trial. Please note that this news release is available on the Investors section of our website, www.wavelifesciences.com. The slide presentation that accompanies this webcast will also be available on our website following this call.

Before we begin, I would

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot